Pfizer Europe MA EEIG
65 products tracked · names used in filings: Pfizer Europe MA EEIG
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Zumrad sasanlimab | Application withdrawn | |
| 🇪🇺 | Fyzoclad adalimumab | Application withdrawn | |
| 🇪🇺 | Raylumis tanezumab | Refused | |
| 🇪🇺 | Hympavzi marstacimab | Authorised | 2024-11-18 |
| 🇪🇺 | Penbraya meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed) | Withdrawn | 2024-11-14 |
| 🇪🇺 | Beqvez (previously Durveqtix) fidanacogene elaparvovec | Withdrawn | 2024-07-24 |
| 🇪🇺 | Emblaveo aztreonam;avibactam | Authorised | 2024-04-22 |
| 🇪🇺 | Velsipity etrasimod | Authorised | 2024-02-16 |
| 🇪🇺 | Elrexfio elranatamab | Authorised | 2023-12-07 |
| 🇪🇺 | Litfulo ritlecitinib | Authorised | 2023-09-15 |
| 🇪🇺 | Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant) | Authorised | 2023-08-23 |
| 🇪🇺 | Vydura rimegepant | Authorised | 2022-04-25 |
| 🇪🇺 | Oxbryta voxelotor | Suspended | 2022-02-14 |
| 🇪🇺 | Prevenar 20 (previously Apexxnar) pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) | Authorised | 2022-02-14 |
| 🇪🇺 | Ngenla somatrogon | Authorised | 2022-02-14 |
| 🇪🇺 | Paxlovid nirmatrelvir;ritonavir | Authorised | 2022-01-28 |
| 🇪🇺 | Cibinqo abrocitinib | Authorised | 2021-12-09 |
| 🇪🇺 | Tukysa tucatinib | Authorised | 2021-02-11 |
| 🇪🇺 | Nyvepria pegfilgrastim | Authorised | 2020-11-18 |
| 🇪🇺 | Daurismo glasdegib | Authorised | 2020-06-26 |
| 🇪🇺 | Ruxience rituximab | Authorised | 2020-04-01 |
| 🇪🇺 | Staquis crisaborole | Withdrawn | 2020-03-27 |
| 🇪🇺 | Amsparity adalimumab | Authorised | 2020-02-13 |
| 🇪🇺 | Talzenna talazoparib | Authorised | 2019-06-20 |
| 🇪🇺 | Lorviqua lorlatinib | Authorised | 2019-05-06 |
| 🇪🇺 | Vizimpro dacomitinib | Authorised | 2019-04-02 |
| 🇪🇺 | Zirabev bevacizumab | Authorised | 2019-02-14 |
| 🇪🇺 | Trazimera trastuzumab | Authorised | 2018-07-26 |
| 🇪🇺 | Mylotarg gemtuzumab ozogamicin | Authorised | 2018-04-19 |
| 🇪🇺 | Besponsa inotuzumab ozogamicin | Authorised | 2017-06-28 |
| 🇪🇺 | Trumenba meningococcal group b vaccine (recombinant, adsorbed) | Authorised | 2017-05-24 |
| 🇪🇺 | Pemetrexed Pfizer (previously Pemetrexed Hospira UK Limited) pemetrexed | Withdrawn | 2017-04-24 |
| 🇪🇺 | Xeljanz tofacitinib | Authorised | 2017-03-22 |
| 🇪🇺 | Daptomycin Hospira daptomycin | Authorised | 2017-03-22 |
| 🇪🇺 | Lifmior etanercept | Lapsed | 2017-02-13 |
| 🇪🇺 | Ibrance palbociclib | Authorised | 2016-11-09 |
| 🇪🇺 | Bortezomib Hospira bortezomib | Withdrawn | 2016-07-22 |
| 🇪🇺 | Palonosetron Hospira palonosetron | Withdrawn | 2016-04-08 |
| 🇪🇺 | Pemetrexed Pfizer (previously Pemetrexed Hospira) pemetrexed | Authorised | 2015-11-19 |
| 🇪🇺 | Duavive oestrogens conjugated;bazedoxifene | Authorised | 2014-12-16 |
| 🇪🇺 | Levetiracetam Hospira levetiracetam | Authorised | 2014-01-07 |
| 🇪🇺 | Inflectra infliximab | Withdrawn | 2013-09-10 |
| 🇪🇺 | Bosulif bosutinib | Authorised | 2013-03-27 |
| 🇪🇺 | Zoledronic Acid Hospira zoledronic acid | Withdrawn | 2012-11-19 |
| 🇪🇺 | Xalkori crizotinib | Authorised | 2012-10-23 |
| 🇪🇺 | Inlyta axitinib | Authorised | 2012-09-03 |
| 🇪🇺 | Nimenrix meningococcal groups A, C, W-135 and Y conjugate vaccine | Authorised | 2012-04-20 |
| 🇪🇺 | Vyndaqel tafamidis | Authorised | 2011-11-16 |
| 🇪🇺 | Topotecan Hospira topotecan | Authorised | 2010-06-09 |
| 🇪🇺 | Nivestim filgrastim | Authorised | 2010-06-07 |
| 🇪🇺 | Prevenar 13 pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) | Authorised | 2009-12-09 |
| 🇪🇺 | Conbriza bazedoxifene | Authorised | 2009-04-17 |
| 🇪🇺 | Retacrit epoetin zeta | Authorised | 2007-12-18 |
| 🇪🇺 | Torisel temsirolimus | Authorised | 2007-11-19 |
| 🇪🇺 | Ecalta anidulafungin | Authorised | 2007-09-20 |
| 🇪🇺 | Toviaz fesoterodine | Authorised | 2007-04-20 |
| 🇪🇺 | Champix varenicline | Authorised | 2006-09-25 |
| 🇪🇺 | Tygacil tigecycline | Authorised | 2006-04-24 |
| 🇪🇺 | Somavert pegvisomant | Authorised | 2002-11-12 |
| 🇪🇺 | Dynastat parecoxib | Authorised | 2002-03-22 |
| 🇪🇺 | Vfend voriconazole | Authorised | 2002-03-19 |
| 🇪🇺 | Rapamune sirolimus | Authorised | 2001-03-13 |
| 🇪🇺 | Enbrel etanercept | Authorised | 2000-02-02 |
| 🇪🇺 | ReFacto AF moroctocog alfa | Authorised | 1999-04-13 |
| 🇪🇺 | BeneFIX nonacog alfa | Authorised | 1997-08-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.